ATE421328T1 - Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren - Google Patents

Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren

Info

Publication number
ATE421328T1
ATE421328T1 AT03723633T AT03723633T ATE421328T1 AT E421328 T1 ATE421328 T1 AT E421328T1 AT 03723633 T AT03723633 T AT 03723633T AT 03723633 T AT03723633 T AT 03723633T AT E421328 T1 ATE421328 T1 AT E421328T1
Authority
AT
Austria
Prior art keywords
cells
sterile
methods
tumorigen
immunogene
Prior art date
Application number
AT03723633T
Other languages
English (en)
Inventor
Martin Haspel
Nicholas Pomato
Michael Hanna
Original Assignee
Intracel Recources Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intracel Recources Llc filed Critical Intracel Recources Llc
Application granted granted Critical
Publication of ATE421328T1 publication Critical patent/ATE421328T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03723633T 2002-02-22 2003-02-21 Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren ATE421328T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35843102P 2002-02-22 2002-02-22

Publications (1)

Publication Number Publication Date
ATE421328T1 true ATE421328T1 (de) 2009-02-15

Family

ID=27765958

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03723633T ATE421328T1 (de) 2002-02-22 2003-02-21 Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren

Country Status (9)

Country Link
US (1) US7628996B2 (de)
EP (1) EP1567175B1 (de)
JP (1) JP2006507214A (de)
CN (1) CN1774255A (de)
AT (1) ATE421328T1 (de)
AU (1) AU2003230553B2 (de)
CA (1) CA2476999C (de)
DE (1) DE60326001D1 (de)
WO (1) WO2003072032A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674456B2 (en) * 2004-06-14 2010-03-09 Charles Wiseman Breast cancer cell lines and uses thereof
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
US20080286249A1 (en) * 2006-01-12 2008-11-20 Varney Timothy R Use of mesenchymal stem cells for treating genetic diseases and disorders
AU2008299318A1 (en) 2007-09-12 2009-03-19 The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center Methods of treating tumors in immune-privileged sites
WO2010022225A1 (en) * 2008-08-20 2010-02-25 Ibc Pharmaceuticals, Inc. Dock-and-lock (dnl) vaccines for cancer therapy
ES2719816T3 (es) 2010-02-26 2019-07-16 Decell Tech Inc Métodos para la descelularización de tejidos
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US20120009644A1 (en) * 2010-07-06 2012-01-12 Cryolife, Inc. Tissue Implants for Implantation and Methods for Preparing the Same
WO2012069067A1 (de) 2010-11-26 2012-05-31 Vakzine Projekt Management Gmbh Verfahren zur herstellung eines immunotherapeutikums
US20150093416A1 (en) * 2013-09-27 2015-04-02 Vaccinogen, Inc. Autologous tumor vaccines and methods
EP3065790B1 (de) 2013-11-04 2020-10-28 LifeCell Corporation Verfahren zur entfernung von alpha-galactose
US10099855B1 (en) 2015-08-14 2018-10-16 II Michael S. Higgins Can liner cinch device and method of use
AU2018378201A1 (en) * 2017-12-04 2020-05-21 Heat Biologics, Inc. Production of cell-based vaccines
CN110124021A (zh) * 2019-05-15 2019-08-16 迪亚思生命科技(武汉)有限公司 一种新型肿瘤疫苗的制备方法
CN112316148A (zh) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 包含血浆的半流体的应用、包含该半流体和活性成分的药物组合物及其制备方法
CN112316147A (zh) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 包含组织细胞的半流体和活性成分的药物组合物以及该组合物的制备方法
WO2022068925A1 (zh) * 2020-09-30 2022-04-07 成都夸常奥普医疗科技有限公司 动物非致病性细胞相关组分的应用和包含该组分的药物组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
DE69027187T2 (de) 1989-06-15 1996-10-31 Rorer Int Overseas Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
EP1216710B1 (de) 1991-10-04 2006-04-05 Whitehead Institute For Biomedical Research Regulierung der systemischen Immunantworten mittels Zytokinen und Antigenen
US6090385A (en) 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US6218166B1 (en) * 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
JP3201610B2 (ja) 1995-03-17 2001-08-27 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 腫瘍を処置する方法
US5532141A (en) 1995-06-13 1996-07-02 Holler; Larry D. Process for obtaining ganglioside lipids
US5788941A (en) 1996-01-31 1998-08-04 Steris Corporation Method of sterilization of bone tussue
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US6506339B1 (en) 1997-02-10 2003-01-14 Biomedical Design, Inc. Method of sterilization
EP1119365A4 (de) 1997-07-24 2003-08-13 Univ Jefferson Zusammensetzung und methode zur verwendung von tumorzellen
US6270723B1 (en) 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US6299873B1 (en) 1998-06-17 2001-10-09 University Of Connecticut Method for improvement of radiation therapy of malignant tumors
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
US6406699B1 (en) 1999-10-05 2002-06-18 Gary W. Wood Composition and method of cancer antigen immunotherapy
US6180357B1 (en) 1999-10-08 2001-01-30 Arius Research, Inc. Individualized patient-specific anti-cancer antibodies

Also Published As

Publication number Publication date
US7628996B2 (en) 2009-12-08
WO2003072032A3 (en) 2005-06-02
EP1567175B1 (de) 2009-01-21
AU2003230553A1 (en) 2003-09-09
CA2476999A1 (en) 2003-09-04
EP1567175A2 (de) 2005-08-31
JP2006507214A (ja) 2006-03-02
WO2003072032A2 (en) 2003-09-04
AU2003230553A2 (en) 2003-09-09
DE60326001D1 (de) 2009-03-12
EP1567175A4 (de) 2006-03-29
US20030228300A1 (en) 2003-12-11
CN1774255A (zh) 2006-05-17
AU2003230553B2 (en) 2008-08-21
CA2476999C (en) 2015-09-15

Similar Documents

Publication Publication Date Title
ATE421328T1 (de) Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren
EP4495133A3 (de) Verfahren zur isolierung von t-zellen mit antigenspezifizität für eine krebsspezifische p53-mutation
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
NO20045354L (no) Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser
SA522432139B1 (ar) بروتينات ربط متعددة الخصوصية لمعالجة السرطان
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
PH12021552023A1 (en) Therapeutic rna for prostate cancer
WO2023049636A3 (en) Cancer therapy compositions and uses thereof
RU2012127685A (ru) Устройства и способы для активной клеточной иммунотерапии рака путем применения опухолевых клеток, уничтоженных при помощи высокого гидростатического давления, и дендритных клеток
EA201690004A1 (ru) Антитела против lamp1 и конъюгаты антитела и лекарственного средства, а также их применение
ATE512668T1 (de) Allogenes tumortherapeutikum
SG162817A1 (en) Methods and compositions.to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma
WO2020036646A3 (en) Cancer neoantigens and their utilities in cancer vaccines and tcr-based cancer immunotherapy
WO2010005704A3 (en) Novel helper plasmid, defective sindbis viral vectors and methods of use thereof
WO2003033520A3 (en) Anticancer vaccine and diganostic methods and reagents
DK1530628T3 (da) Fremgangsmåde til fremstilling af temperaturinducerede tumorcellelysater til anvendelse som immunogene forbindelser
CY1111522T1 (el) 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο
WO2012026820A3 (en) Immunotherapeutic method for treating prostate cancer
DE602004015418D1 (de) Rekombinantes mva und verfahren zur erzeugung davon
EE200200157A (et) Vaktsiin
EA200700598A1 (ru) Противоопухолевая вакцина, способ получения противоопухолевой вакцины и способ проведения противоопухолевой иммунотерапии
Inogés et al. Feasibility of idiotype vaccination in relapsed B-cell malignancies
ATE473756T1 (de) Pharmazeutische zusammensetzung zur behandlung oder prävention von ovarialkrebs
WO2006105255A3 (en) Cancer vaccines and therapeutic methods
WO2006105279A3 (en) Defective sindbis viral vectors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties